A61P 19/10
For osteoporosis
Official title: for osteoporosis
A61P19/10 (For osteoporosis) appears on 7,834 US grants and 11,231 published applications in this corpus.
Search patents in A61P- Granted patents
- 7,834
- Published applications
- 11,231
- Assignees
- 2,924
- Inventors
- 18,370
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 9 | 0 |
| 1992 | 8 | 0 |
| 1993 | 13 | 0 |
| 1994 | 23 | 0 |
| 1995 | 42 | 0 |
| 1996 | 58 | 0 |
| 1997 | 73 | 0 |
| 1998 | 104 | 0 |
| 1999 | 145 | 0 |
| 2000 | 130 | 0 |
| 2001 | 179 | 58 |
| 2002 | 259 | 302 |
| 2003 | 226 | 529 |
| 2004 | 196 | 683 |
| 2005 | 198 | 636 |
| 2006 | 276 | 579 |
| 2007 | 302 | 609 |
| 2008 | 297 | 641 |
| 2009 | 328 | 851 |
| 2010 | 465 | 884 |
| 2011 | 461 | 767 |
| 2012 | 477 | 700 |
| 2013 | 584 | 557 |
| 2014 | 551 | 571 |
| 2015 | 431 | 435 |
| 2016 | 333 | 393 |
| 2017 | 314 | 379 |
| 2018 | 259 | 315 |
| 2019 | 264 | 275 |
| 2020 | 202 | 258 |
| 2021 | 190 | 229 |
| 2022 | 113 | 166 |
| 2023 | 95 | 117 |
| 2024 | 93 | 132 |
| 2025 | 94 | 105 |
| 2026 | 27 | 60 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of using a needle assisted injection device having reduced trigger force18 Aug 2026US 12,708,710 B2Antares Pharma, Inc.
- Diacylglycerol acyl transferase 2 inhibitors11 Aug 2026US 12,703,696 B2Pfizer Inc.
- GIP agonist compounds and methods11 Aug 2026US 12,703,729 B2Zealand Pharma A/S
- Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof11 Aug 2026US 12,703,742 B2
- Pharmaceutical composition for preventing or treating bone diseases28 Jul 2026US 12,691,084 B2Industry Foundation of Chonnam National University
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Method for isolating fetuin-a8 Oct 2026US 2026/0308213 A1PreviPharma GmbH
- Stabilized analogues of calcitonin8 Oct 2026US 2026/0308222 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Treatment and prevention of osteoporosis in high body mass index individuals17 Sep 2026US 2026/0273025 A1Radius Health, Inc.
Most cited
By later US patents
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010